Congenitally Corrected Transposition of the Great Arteries

Oncology·MeSH: Heart Failure

Prevalence

5.0 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Congenitally Corrected Transposition of the Great Arteries?

There are 1 clinical trial targeting Congenitally Corrected Transposition of the Great Arteries tracked by BioSniper.

What is the prevalence of Congenitally Corrected Transposition of the Great Arteries?

The estimated prevalence of Congenitally Corrected Transposition of the Great Arteries is approximately 5.0 per 100,000 population.

Deep-dive into Congenitally Corrected Transposition of the Great Arteries

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Congenitally Corrected Transposition of the Great Arteries — Drugs in Development & Clinical Trials | BioSniper